(Q40783265)

English

Recombinant Human Tumor Necrosis Factor Administered as a 24-Hour Intravenous Infusion. A Phase I and Pharmacologic Study

scientific article published on September 7, 1988

Statements

Recombinant Human Tumor Necrosis Factor Administered as a 24-Hour Intravenous Infusion. A Phase I and Pharmacologic Study (English)
Frei E 3rd
13
1039-1044

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit